News

Nasdaq1mon
Pharvaris Announces Abstract Acceptance for Presentation at Key Angioedema Congresses in 2025 - Nasdaq
Title: Clinical Validation of a Novel Biomarker Assay to Characterize Bradykinin-Mediated Angioedema in Prospective and Biobank Plasma Samples Presenter: Evangelia Pardali, Ph.D. Format: Oral ...
Financial Post1mon
Aptose Selected for Prestigious Oral Presentation of Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the ... - Financial Post
Details of the presentation are as follows: Title: TUSCANY Study of Safety and Efficacy of Tuspetinib Plus Standard of Care Venetoclax and Azacitidine in Study Participants with Newly Diagnosed AML ...
PharmiWeb2mon
Faron Announces Acceptance of Bexmarilimab Phase II Data for Oral Presentation at ASCO 2025
TURKU, FI / ACCESS Newswire / April 24, 2025 / Faron Pharmaceuticals Ltd. (AIM:FARN), a clinical-stage biopharmaceutical company developing novel immunotherapies, announces that new Phase II data from ...
Law2mon
Lawyers Will Have 2 Minutes Uninterrupted as Court Tests New Oral Argument Format
Under the leadership of newly installed Chief Justice Nels S. D. Peterson, the high court is testing a new oral argument format that affords appellate counsel "two minutes of uninterrupted time ...
Yahoo Finance3mon
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025 - Yahoo Finance
Abpro has a strategic partnership with Celltrion for worldwide development and commercialization of AB-102/CT-P72WOBURN, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP ...
Seeking Alpha3mon
CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™) - Seeking Alpha
CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™) Mar. 25, 2025 8:00 AM ET CervoMed Inc ...
Morningstar3mon
CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™) - Morningstar
Session Name: Advances in PD, LBD, and MSA Drug Development Presentation Date and Time: Saturday, April 5th, 2025, 18.25-18.40 pm CET ...
manilatimes5mon
UST student wins best oral presentation at SG SSI
A CLASS 2024 alumnus of the University of Santo Tomas (UST) College of Science won best oral presentation during the National University of Singapore Science Summer Institute (NUS SSI) 2024 at the NUS ...
Business Insider8mon
CervoMed to Deliver Oral Presentation at the 8th International Lewy Body Dementia Conference - Markets Insider
Format: Oral Presentation Session Name: Therapeutics in DLB Session Date and Time: Friday, January 31, 2025, 14.00-15.30 pm Local Time About CervoMed ...
Yahoo Finance9mon
BioAtla Announces Upcoming Oral Presentation at the Society for Melanoma Research 21st International Congress - Yahoo Finance
SAN DIEGO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...
Yahoo Finance9mon
BioAtla Announces Upcoming Oral Presentation at the Society for Melanoma Research 21st International Congress - Yahoo Finance
SAN DIEGO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...
Yahoo Finance1y
Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical Results - Yahoo Finance
Format: Oral Presentation Date/Time: 18:30-19:30 Central European Time (CEST), July 11, 2024 Webcast Details Immutep will host a webcast to discuss the clinical data. A replay of the webcast will be ...